1.
Relationship between painful manifestations and the use of hydroxyurea in children and adolescents with sickle cell disease. RSD [Internet]. 2020 Oct. 14 [cited 2025 Dec. 14];9(10):e6949109046. Available from: https://rsdjournal.org/rsd/article/view/9046